US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Cleo Diagnostics Ltd (COV) 銘柄情報

Cleo Diagnostics Ltd (COV)

0.525

0.015

( 2.94% )

更新日時： 12:33:56

Cleo Diagnostics Ltd (COV) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.525

( 2.94% )

買値

0.51

売値

0.525

出来高

10,175

0.525 日の範囲 0.525

0.335 52 週間の範囲 0.90

時価総額

前日終値

0.51

始値

0.525

時刻

最終取引時間

12:31:37

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 169,467

発行済株式数

136,862,085

配当利回り

PER

-16.42

1 株当たり利益 (EPS)

-0.03

歳入

2.56M

純利益

-4.03M

Cleo Diagnostics Ltd, a biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determi... Cleo Diagnostics Ltd, a biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.cleodx.com

本社

Melbourne, Australia

設立

2026

Cleo Diagnostics Ltd is listed in the sector of the オーストラリア証券取引所 with ticker COV. The last closing price for Cleo Diagnostics was AUD0.51. Over the last year, Cleo Diagnostics shares have traded in a share price range of AUD 0.335 to AUD 0.90.

Cleo Diagnostics currently has 136,862,085 shares in issue. The market capitalisation of Cleo Diagnostics is AUD71.85 million. Cleo Diagnostics has a price to earnings ratio (PE ratio) of -16.42.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.005	-0.943396226415	0.53	0.55	0.49	114879	0.52224386	DE
4	-0.135	-20.4545454545	0.66	0.7	0.49	156237	0.60039407	DE
12	0.045	9.375	0.48	0.75	0.465	164646	0.59419814	DE
26	-0.125	-19.2307692308	0.65	0.9	0.4575	245677	0.62918399	DE
52	0.17	47.8873239437	0.355	0.9	0.335	210163	0.55526542	DE
156	0.295	128.260869565	0.23	0.9	0.14	167983	0.43284105	DE
260	0.295	128.260869565	0.23	0.9	0.14	167983	0.43284105	DE

COV - Frequently Asked Questions (FAQ)

What is the current Cleo Diagnostics Ltd share price?

The current share price of Cleo Diagnostics Ltd is AUD 0.525

How many Cleo Diagnostics Ltd shares are in issue?

Cleo Diagnostics Ltd has 136,862,085 shares in issue

What is the market cap of Cleo Diagnostics Ltd?

The market capitalisation of Cleo Diagnostics Ltd is AUD 71.85M

What is the 1 year trading range for Cleo Diagnostics Ltd share price?

Cleo Diagnostics Ltd has traded in the range of AUD 0.335 to AUD 0.90 during the past year

What is the PE ratio of Cleo Diagnostics Ltd?

The price to earnings ratio of Cleo Diagnostics Ltd is -16.42

What is the cash to sales ratio of Cleo Diagnostics Ltd?

The cash to sales ratio of Cleo Diagnostics Ltd is 27.51

What is the registered address of Cleo Diagnostics Ltd?

The registered address for Cleo Diagnostics Ltd is 480 Collins Street, Melbourne, Victoria, 3000

What is the Cleo Diagnostics Ltd website address?

The website address for Cleo Diagnostics Ltd is www.cleodx.com

nowwhat2

nowwhat2 4分前

https://www.youtube.com/watch?v=JNhayv6hBeo
https://investorshub.advfn.com/uimage/uploads/2026/6/12/udfnigold_june_11_3y_w_asian_guy.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/dlvrrsilver_june_11_3y_w_asian_guy.jpg

nowwhat2

nowwhat2 5分前

https://www.youtube.com/watch?v=JNhayv6hBeo
https://investorshub.advfn.com/uimage/uploads/2026/6/12/udfnigold_june_11_3y_w_asian_guy.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/12/dlvrrsilver_june_11_3y_w_asian_guy.jpg

axelvento

axelvento 5分前

Ovarian cancer CAR-T therapy, lira-cel, presentation to highlight positive survival observations from ongoing Phase 1 clinical trial

Breast cancer vaccine presentation to include final Phase 1 data showing all major primary endpoints were met and protocol-defined immune responses in 7

JohnnyRotton

JohnnyRotton 13分前

Wasn't to get sellers cause no one bought my sell order, cant get out now. Stuck. Just a small order.

jimr1717

jimr1717 14分前

I seriously doubt Nelson or Hawkins care who their marks are that they dump their shares on

ElectricDwarf15

ElectricDwarf15 17分前

Stuck short INHD after the T12 halt and looking to connect with anyone holding long shares who wants to exit.

I'm with Cobra DM me if interested.

knrorrel

knrorrel 18分前

$PAVD - It kicks off today. You might think—after the stock was bought up at a really nice, low price yesterday—that we’re going to skyrocket today, and all the people who didn't have the guts to buy yesterday and have been waiting on the sidelines will jump in; the stock could become a multi-dolla

ap17

Word on the street, the village Idiot, aka sims is going to change the traffic pattern. LMFAO
Don't forget! This about YOU! OUCH!!!
Might want to change that traffic pattern....so you can sit! LMFAO!!

https://www.instagram.com/p/DSS1QQ4EZk9/

Elon Musk: congratulations! Our country is lucky to have you…and you have excelled through hard work to help create the modern world more than anyone since Steve Jobs. You also are a father of many kids and are active in their lives. You have a great sense of humor and wit, and never before in histo

ace65

Up 100% ...excellent day with massive volume.
No complaints here.
Bought a chunk at .0004 and added .0005s.
Looking like .00s are coming.

knrorrel

knrorrel 23分前

It kicks off today. You might think—after the stock was bought up at a really nice, low price yesterday—that we’re going to skyrocket today, and all the people who didn't have the guts to buy yesterday and have been waiting on the sidelines will jump in; the stock could become a multi-dollar runner—

jour_trader

jour_trader 24分前

Valid question. Elite was up against a billion dollar organization known for dragging out patent protections time and time again. I think Elite and Accord’s cases brought to light the craziness of what Purdue was doing and perhaps the cases prevented further attempts at extending patents that the co

knrorrel

knrorrel 26分前

GM - watch $PAVS today, bid / ask moving higher 🚀

ddls

You know the stock is in trouble when even ddls's posts start thinning out.

Everyone's waiting for financials next year to see if any progress is being made here. Until then we should call BioElectronics Boring BIEL.

jour_trader

jour_trader 29分前

Yes, precisely. Now they can include with more certainty the financial value of Oxy in the DCF.

jour_trader

jour_trader 30分前

Nasrat will likely now be able to provide more clarification with case officially ending. Been a long road with a decent outcome. Eager to watch Accord to see what takes place with them and if they have first to file rights.

mrwrn2010

mrwrn2010 31分前

Saw that too. Possible M&A clause? 👀🧐🤔

ace65

WOW...just saw the eod Level II .WTF happened.
A high of .0037 million bought.

mrwrn2010

mrwrn2010 32分前

Even more reason to transfer full Adderall rights to Elite now. Methadone and Ropinirole alone ain’t gonna get us anywhere near the growth we need in the near term.

jour_trader

jour_trader 33分前

Also, #3 - should Elite sell or transfer ANDA…

mrwrn2010

mrwrn2010 34分前

It seems like Elite can amend the existing filing from a P IV to a P III if I’m reading the document correctly. So still, doesn’t make sense. Let us get the approval whenever and we’ll wait to launch as soon as those patents are up (assuming no one else has exclusivity).

Just give me $1.50

Just give me $1.50 36分前

Elite's attorneys are regarded, just like it's CEO.

We ain't launching Oxy until late 2028..........AT BEST.

jour_trader

jour_trader 37分前

I read that as submission to the FDA as in it buys Purdue even more time beyond the patent expiration date.

Lord Andreti

Lord Andreti 38分前

It’s far from going to no bid. Bid is high AF right now and not something you see daily around the OTC market.

Something is brewing and this is for sure going places (bid still gives the biggest tells)…I just don’t think it’s going be that big of a deal, anymore, after this crap.

OMOLIVES

OMOLIVES 38分前

Also, look at the past six Months. They had 7.5 - 1 Billion volume days over the past six Months. Backlog, bottleneck....fucked.

Cleo Diagnostics

Bluesky Digital Assets

Loyalist Exploration

BNP Paribas Issuance BV

0.658% until 7jan2041 0....

Nemaura Medical

0.75% IL TREASURY 34

Ariston Holding NV (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。